Pharmacosmos, a world leader in developing and producing carbohydrates for pharmaceutical applications, is the first company to introduce DEAE-Dextran in a Pharmaceutical Quality.
DEAE-Dextran is a polycationic derivative of dextran. Its commercial applications include use as a vaccine adjuvant, a transfection agent for gene therapy, and as an ingredient in cholesterol lowering products.
"The introduction of our DEAE-Dextran Pharmaceutical Quality is an important addition to our portfolio of carbohydrates produced according to GMP. This will enable our pharmaceutical customers to continue to expand their use of DEAE-Dextran while meeting increasingly high regulatory requirements" says Dr Lars Christensen, President and CEO at Pharmacosmos.
Pharmacosmos is the first company to offer GMP certified DEAE-Dextran. The certificate of GMP compliance has been issued by the Danish Medicines Agency. Pharmacosmos is also the only manufacturer of dextran that holds certificates from the US FDA and the European Directorate for the Quality of Medicines (EDQM).
For additional information on the new pharmaceutical quality DEAE-Dextran please visit www.dextran.com
Media: Tobias Christensen, VP Corporate Development & Strategy, E: email@example.com, T: +45 5948 5959
Customer inquiries: Anne-Marie Oerkild, International Sales and Business Director, Carbohydrates, E: firstname.lastname@example.org or email@example.com, T: +45 5948 5959
Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)
Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines
Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).
©2019 PHARMACOSMOS A/S
This website contains information on products which is targeted to a wide range of audiences outside US and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Monofer®, CosmoFer® and Uniferon® are a registered trademarks of Pharmacosmos A/S. All rights reserved.